WeHand

About:

WeHand is a biopharmaceutical company focusing on the development of hypoglycemic drugs.

Website: http://www.wehand-bio.cn

Top Investors: Cowin Capital, Northern Light Venture Capital, Lapam Capital, Lang Sheng Investment

Description:

WeHand is a biopharmaceutical company that focuses on innovative drugs for major diseases such as metabolic diseases, malignant tumors, anti-inflammatory immunity, and so on. WeHand focuses on strategic planning and top-level design, adheres to the concept of open cooperation and innovative development, integrates multidisciplinary and cross-field systems, and quickly transforms original technology into products and realizes commercial value through the incubation of original innovative drugs, high-standard clinical research, and customized intelligent production lines.